Cellebrite DI (CLBT) Depreciation & Amortization (CF) (2020 - 2025)

Cellebrite DI's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $3.9 million for Q4 2025.

• On a quarterly basis, Depreciation & Amortization (CF) rose 44.41% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $11.9 million, a 11.88% increase from a year earlier, with the FY2025 full-year figure at $11.9 million, up 11.88% from the prior year.
• Depreciation & Amortization (CF) climbed to $3.9 million in Q4 2025 per CLBT's latest filing, from $2.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $3.9 million in Q4 2025 and bottomed at $1.5 million in Q1 2021.
• The 5-year median for Depreciation & Amortization (CF) is $2.5 million (2022), against an average of $2.4 million.
• Biggest YoY gain for Depreciation & Amortization (CF) was 44.41% in 2025; the steepest drop was 1.83% in 2025.
• Year by year, Depreciation & Amortization (CF) stood at $1.8 million in 2021, then surged by 38.92% to $2.5 million in 2022, then gained by 3.77% to $2.6 million in 2023, then advanced by 4.36% to $2.7 million in 2024, then jumped by 44.41% to $3.9 million in 2025.
• Per Business Quant, the three latest CLBT Depreciation & Amortization (CF) figures stand at $3.9 million (Q4 2025), $2.7 million (Q3 2025), and $2.6 million (Q2 2025).